Independent Non-Executive Chairman of Integral Diagnostics James Hall Buys 23% More Shares

Simply Wall St.

Jun 29

Even if it's not a huge purchase, we think it was good to see that James Hall, the Independent Non-Executive Chairman of Integral Diagnostics Limited (ASX:IDX) recently shelled out AU$101k to buy ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2647401349"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2647401349\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2647401349?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","is_english":true,"pubTime":"2026-06-29 06:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2647401349","market":"sg","top_or_hot":-1,"title":"Independent Non-Executive Chairman of Integral Diagnostics James Hall Buys 23% More Shares","media":"Simply Wall St.","content":"<div>\n<p>Even if it's not a huge purchase, we think it was good to see that James Hall, the Independent Non-Executive Chairman of Integral Diagnostics Limited (ASX:IDX) recently shelled out AU$101k to buy ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-idx/integral-diagnostics-shares/news/independent-non-executive-chairman-of-integral-diagnostics-j\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Independent Non-Executive Chairman of Integral Diagnostics James Hall Buys 23% More Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIndependent Non-Executive Chairman of Integral Diagnostics James Hall Buys 23% More Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-29 06:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/healthcare/asx-idx/integral-diagnostics-shares/news/independent-non-executive-chairman-of-integral-diagnostics-j><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Even if it's not a huge purchase, we think it was good to see that James Hall, the Independent Non-Executive Chairman of Integral Diagnostics Limited (ASX:IDX) recently shelled out AU$101k to buy ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/healthcare/asx-idx/integral-diagnostics-shares/news/independent-non-executive-chairman-of-integral-diagnostics-j\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INTEU","symbol_name":"Integral Acquisition Corporation 1","start_time":0,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-idx/integral-diagnostics-shares/news/independent-non-executive-chairman-of-integral-diagnostics-j","article_id":"2647401349","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-idx/integral-diagnostics-shares/news/independent-non-executive-chairman-of-integral-diagnostics-j","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2647401349","pubTimestamp":1782684164,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Even if it's not a huge purchase, we think it was good to see that James Hall, the Independent Non-Executive Chairman...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"INTEU":"Integral Acquisition Corporation 1","BK7124":"保健护理服务","IDX.AU":"INTEGRAL DIAGNOSTICS LTD"},"translate_title":"Integral Diagnostics独立非执行主席James Hall增持23%股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INTEU":1.5,"IDX.AU":1},"content_text":"Even if it's not a huge purchase, we think it was good to see that James Hall, the Independent Non-Executive Chairman of Integral Diagnostics Limited (ASX:IDX) recently shelled out AU$101k to buy stock, at AU$1.96 per share.    While we're hesitant to get too excited about a purchase of that size, we do note it increased their holding by a solid 23%.     AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.Advertisement Integral Diagnostics Insider Transactions Over The Last Year   In fact, the recent purchase by James Hall was the biggest purchase of Integral Diagnostics shares made by an insider individual in the last twelve months, according to our records.     So it's clear an insider wanted to buy, at around the current price, which is AU$2.00.  That means they have been optimistic about the company in the past, though they may have changed their mind.  If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value.   The good news for Integral Diagnostics share holders is that insiders were buying at near the current price.      Integral Diagnostics insiders may have bought shares in the last year, but they didn't sell any.    The average buy price was around AU$2.21.     These transactions suggest that insiders have considered the current price attractive.       You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below.  If you want to know exactly who sold, for how much, and when, simply click on the graph below!  View our latest analysis for Integral Diagnostics ASX:IDX Insider Trading Volume June 28th 2026 There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.   Insider Ownership Of Integral Diagnostics  For a common shareholder, it is worth checking how many shares are held by company insiders.  We usually like to see fairly high levels of insider ownership.   Insiders own 1.6% of Integral Diagnostics shares, worth about AU$12m, according to our data.   However, it's possible that insiders might have an indirect interest through a more complex structure.   We do generally prefer see higher levels of insider ownership.   So What Does This Data Suggest About Integral Diagnostics Insiders?  It is good to see the recent insider purchase.    And the longer term insider transactions also give us confidence.   Insiders likely see value in Integral Diagnostics shares, given these transactions (along with notable insider ownership of the company).      In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Integral Diagnostics.    Our analysis shows 3 warning signs for Integral Diagnostics (2 are a bit concerning!) and we strongly recommend you look at these before investing.   But note: Integral Diagnostics may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}